n.laurent

TL2 · Monterrey

Contributes reviews on supplier material. Based in Monterrey.

Joined 21 April 2025 · last posted 6d

66Posts here

2Topics

0Solutions

1.2kLikes received

1.6kLikes given

24Badges

204Days visited

4.9kPosts read

Recent activity

Full stream

A site rotation scheme that is easy enough to actually follow Replied, post #121 · Practice › Administration · 22 Jul 2026 · 3 likes Noted, and thank you for writing it out rather than summarising it.
Seven-day rolling means and why weekly readings mislead Replied, post #70 · Outcomes › Progress reports · 20 Jul 2026 · 2 likes Post #69 is the version of this I will quote in future. One addition. Seasonal patterns: some people report weight loss is slower in winter than summer. Body…
Revisiting: The best-written scientific paper you have read Replied, post #100 · Lounge › Off topic · 18 Jul 2026 · 2 likes Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not. A single observation, in a thread that…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #80 · Analytics › Impurities & related substances · 15 Jul 2026 · 12 likes Relative response factors mean impurities are not detected in proportion to how much of them is present. A one per cent peak is not one per cent by mass unless the…
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #14 · Compounds › Secretagogues & GH axis · 29 Jun 2026 · 3 likes This settles it for me, at least until somebody posts a reason it should not.
Coming back to: A structured critique template this community uses Replied, post #34 · Evidence › Study critique · 15 Jun 2026 · 0 likes Adding the measurement that post #31 says would settle it. Reading this structured critique template thread as someone who came in with a fixed view: the third and…
Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #17 · Compounds › Semaglutide · 6 Jun 2026 · 0 likes Picking up post #16: that is the part I would want checked first. The oral formulation is a genuinely different pharmaceutical problem from the injectable and shares…
Two scans six weeks apart on different machines: a cautionary tale Replied, post #25 · Outcomes › Body composition · 24 May 2026 · 15 likes That is a fair summary of where the discussion has got to.
Molecular mass of semaglutide and why the figure differs between sources Replied, post #42 · Compounds › Semaglutide · 23 Apr 2026 · 4 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
Second pass at: Metformin co-administration and additive GI effects Replied, post #81 · Practice › Interactions · 8 Apr 2026 · 13 likes This follows post #78 rather than contradicting it. A supplement is a drug for interaction purposes, and the fact that it is sold without a prescription tells you…
Pharmacy supply in the UK and the questions you will be asked Replied, post #105 · Regional › UK & Ireland · 4 Apr 2026 · 0 likes I have been on both sides of the pharmacy supply argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
Restarting after a long gap: what the labelling implies — the long version Replied, post #9 · Practice › Dosing & titration · 30 Mar 2026 · 5 likes Research-use-only material is not a licensed product and no labelling covers it. Everything in this subcategory about published schedules describes what was done in…